• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.肝细胞癌:一种罕见的眼眶转移瘤。
Case Rep Oncol Med. 2020 Feb 26;2020:7526042. doi: 10.1155/2020/7526042. eCollection 2020.
2
Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor.肝细胞癌转移表现为上颌窦肿瘤和球后肿瘤。
Vojnosanit Pregl. 2011 Apr;68(4):359-62. doi: 10.2298/vsp1104359k.
3
Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle.年轻非肝硬化患者的肝细胞癌心脏转移,累及左心室。
Ann Hepatol. 2012 May-Jun;11(3):392-4.
4
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.肝细胞癌肝外转移患者的临床特征与预后
World J Gastroenterol. 2007 Jan 21;13(3):414-20. doi: 10.3748/wjg.v13.i3.414.
5
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].[德国的肝细胞癌。一所大学诊所100例连续患者的流行病学、病因、临床情况及预后]
Z Gastroenterol. 1997 Dec;35(12):1059-67.
6
Intraconal Metastasis Leading to Diagnosis of Hepatocellular Carcinoma.导致肝细胞癌诊断的锥内转移
Middle East J Dig Dis. 2020 Jan;12(1):48-51. doi: 10.15171/mejdd.2020.164.
7
A rare and challenging case of extrahepatic costal metastases from an unknown primary hepatocellular carcinoma.一例罕见且具有挑战性的原发性不明肝细胞癌肝外肋骨转移病例。
Gastroenterol Hepatol Bed Bench. 2024;17(1):93-99. doi: 10.22037/ghfbb.v17i1.2812.
8
Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.肝细胞癌合并胆管癌:泰国人群的临床特征及预后研究
J Hepatobiliary Pancreat Surg. 2006;13(6):537-42. doi: 10.1007/s00534-006-1117-1. Epub 2006 Nov 30.
9
Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible.无法切除的肝细胞癌伴下颌骨孤立转移。
Am Surg. 2008 Apr;74(4):346-9.
10
[A clinicopathological study of extrahepatic metastasis in autopsy cases of hepatocellular carcinoma with or without cirrhosis].[肝细胞癌伴或不伴肝硬化尸检病例肝外转移的临床病理研究]
Nihon Ika Daigaku Zasshi. 1990 Oct;57(5):384-96. doi: 10.1272/jnms1923.57.384.

引用本文的文献

1
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.从实验室到临床:癌症转移检测与治疗变革中的技术创新
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
2
From Vision Changes to Hospice: The Rapid Progression of Orbital Metastasis in Hepatocellular Carcinoma.从视力变化到临终关怀:肝细胞癌眼眶转移的快速进展
Cureus. 2025 Mar 9;17(3):e80288. doi: 10.7759/cureus.80288. eCollection 2025 Mar.
3
Ocular Metastatic Tumor in a Patient With Hepatocellular Carcinoma.一名肝细胞癌患者的眼部转移性肿瘤
Cureus. 2024 Nov 25;16(11):e74435. doi: 10.7759/cureus.74435. eCollection 2024 Nov.
4
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.基于微小RNA和RNA结合蛋白的肝胆癌骨转移调控及潜在治疗策略
Cells. 2024 Nov 21;13(23):1935. doi: 10.3390/cells13231935.
5
Comprehensive model for simultaneous monitoring of primary tumor to metastatic cancer utilizing Prkdc and Il2rg double knockout mice.利用 Prkdc 和 Il2rg 双基因敲除小鼠对原发性肿瘤到转移性癌症进行同步监测的综合模型。
Sci Rep. 2024 Oct 9;14(1):23531. doi: 10.1038/s41598-024-75493-z.
6
Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature.以眶内转移为首发表现的肝细胞癌及其联合双免疫治疗的疗效:病例报告及文献复习。
Am J Case Rep. 2024 Jun 3;25:e944002. doi: 10.12659/AJCR.944002.
7
New approach for hepatocellular carcinoma treatment.肝细胞癌治疗的新方法。
J Med Life. 2022 Jan;15(1):138-143. doi: 10.25122/jml-2021-0088.
8
LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.长链非编码RNA-URHC作为竞争性内源RNA,通过竞争性结合miR-5007-3p调控肝癌中DNAJB9的表达。
Evid Based Complement Alternat Med. 2021 Oct 7;2021:3031482. doi: 10.1155/2021/3031482. eCollection 2021.

本文引用的文献

1
An unusual initial presentation of hepatocellular carcinoma as a sellar mass.肝细胞癌以鞍区肿块为首发表现的罕见病例。
J Nat Sci Biol Med. 2015 Jul-Dec;6(2):471-4. doi: 10.4103/0976-9668.160045.
2
A case of hepatocellular carcinoma in an elder man with metastasis to the nasopharynx.一名老年男性肝细胞癌伴鼻咽癌转移病例。
Int J Clin Exp Pathol. 2015 May 1;8(5):5919-23. eCollection 2015.
3
Orbital metastasis from hepatocellular carcinoma.肝细胞癌的眼眶转移
Rev Esp Enferm Dig. 2015 Apr;107(4):231.
4
Retrobulbar metastasis and intracranial invasion from postoperative hepatocellular carcinoma: A case report and review of the literature.术后肝细胞癌的球后转移和颅内侵犯:一例报告及文献复习
Oncol Lett. 2015 Feb;9(2):721-726. doi: 10.3892/ol.2014.2733. Epub 2014 Nov 24.
5
Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective.转移性肝细胞癌的流行病学:全国性视角
Dig Dis Sci. 2014 Nov;59(11):2813-20. doi: 10.1007/s10620-014-3229-9. Epub 2014 Jun 6.
6
Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.对于超出改良国际抗癌联盟(UICC)T1期的肝细胞癌患者,需要通过额外的分期手段筛查肝外转移。
Hepatogastroenterology. 2013 Mar-Apr;60(122):328-32. doi: 10.5754/hge12721.
7
Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report.一名既往接受原位肝移植的 HIV 与 HBV 合并感染患者发生肝细胞癌眼眶转移:病例报告
Case Rep Ophthalmol Med. 2011;2011:549270. doi: 10.1155/2011/549270. Epub 2011 Dec 20.
8
Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma.探讨肝癌肝外转移切除术的作用。
Surg Oncol. 2012 Jun;21(2):95-101. doi: 10.1016/j.suronc.2011.01.005. Epub 2011 Mar 11.
9
Orbital metastases: diagnosis and course.眼眶转移瘤:诊断与病程
Br J Ophthalmol. 1997 May;81(5):386-90. doi: 10.1136/bjo.81.5.386.

肝细胞癌:一种罕见的眼眶转移瘤。

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.

作者信息

Protopapa Maria-Nikoletta, Lagadinou Maria, Papagiannis Theodoros, Gogos Charalambos A, Solomou Elena E

机构信息

University of Patras Medical School, Rion 26500, Greece.

出版信息

Case Rep Oncol Med. 2020 Feb 26;2020:7526042. doi: 10.1155/2020/7526042. eCollection 2020.

DOI:10.1155/2020/7526042
PMID:32158574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7061109/
Abstract

Hepatocellular carcinoma (HCC) represents the most common type of primary cancer of the liver and is associated with poor prognosis. It is the most common cause of death in cirrhotic patients and in different studies was shown as the third most common cause of cancer-related deaths worldwide. Each year, approximately half a million people are diagnosed with HCC. In recent decades, the prognosis of patients with HCC has improved because more cases are diagnosed and treated at early stages; high-risk patients (i.e., with chronic HBV or HCV infection) are followed more often for the possibility of HCC, and novel treatment options such as locoregional therapy are used with better overall results. The extrahepatic metastases represent a poor prognostic factor. The most common sites of metastasis in advanced hepatocellular carcinoma are the lung (44%), portal vein (35%), and portal lymph nodes (27%). Also, intra-abdominal lymph nodes and bones are common sites. Orbital metastases rarely occur, representing the 3-7% of orbital masses. These metastases are usually found in advanced tumor stages. The mechanism of metastasis to the orbit is difficult to determine. A hematogenous route, as for other primary neoplasms of the abdomen, may be suspected. Tumor cells may circulate through the vena cava, beyond the pulmonary filter to the heart, and finally be distributed to the orbital region through the arterial systemic circulation. We describe herein a case of an adult male with liver cirrhosis due to alcohol abuse who presented with concomitant diagnosis of HCC and orbit metastasis.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌类型,预后较差。它是肝硬化患者最常见的死亡原因,在不同研究中被列为全球癌症相关死亡的第三大常见原因。每年约有50万人被诊断为HCC。近几十年来,HCC患者的预后有所改善,因为更多病例在早期被诊断和治疗;高危患者(即慢性HBV或HCV感染患者)因有患HCC的可能性而接受更频繁的随访,并且诸如局部区域治疗等新的治疗选择取得了更好的总体效果。肝外转移是一个不良预后因素。晚期肝细胞癌最常见的转移部位是肺(44%)、门静脉(35%)和门静脉淋巴结(27%)。此外,腹腔内淋巴结和骨骼也是常见部位。眼眶转移很少见,占眼眶肿块的3 - 7%。这些转移通常在肿瘤晚期出现。转移至眼眶的机制难以确定。如同腹部其他原发性肿瘤一样,可能怀疑是血行转移途径。肿瘤细胞可能通过腔静脉循环,越过肺循环滤过屏障到达心脏,最终通过动脉系统循环分布至眼眶区域。我们在此描述一例因酗酒导致肝硬化的成年男性病例,该患者同时被诊断为HCC和眼眶转移。